Search - tctmd.com

Displaying 21 - 40 of 103

Sort: Relevancy | Date

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Presenter: Adrian P. Banning, Ted Feldman, Bernard Prendergast

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

Presenter: Kurt Huber, Jamil Abdalla Saad, Antonio Gutierrez, MD

October 31, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

Presenter: Kurt Huber, Jamil Abdalla Saad, Kara Denby, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD

October 31, 2017

Presentation TCT 2017

Anticoagulation Following DVT/PE Intervention: What, When, Why, and for How Long?

Presenter: Michael R. Jaff, Robert A. Lookstein, Teresa L. Carman

October 30, 2017

News Daily News

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Todd Neale

October 25, 2017

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Todd Neale

October 12, 2017

Podcast

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

October 11, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Todd Neale

September 27, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

Caitlin E. Cox

September 19, 2017

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

Advertisement

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Anticoagulation Following DVT/PE Intervention: What, When, Why, and for How Long?

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

NOAC Bleeding Risk Rises With Several Drug Combinations

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content